Company profile for Cosette Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cosette Pharmaceuticals, Inc. is a generic pharmaceutical company specializing in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories. The company was formed when Avista Capital Partners, a leading private equity firm focused on growth-oriented healthcare businesses, purchased the extended topicals and dermatology portfolio ...
Cosette Pharmaceuticals, Inc. is a generic pharmaceutical company specializing in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories. The company was formed when Avista Capital Partners, a leading private equity firm focused on growth-oriented healthcare businesses, purchased the extended topicals and dermatology portfolio of G&W Laboratories in December 2018.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 Crossing Boulevard, 4th Floor Bridgewater, NJ 08807
Telephone
Telephone
1-800-922-1038
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/australian-government-rejects-cosettes-proposed-mayne-pharma-buyout-citing-national-interest

FIERCE PHARMA
21 Nov 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218273

FDA
10 Nov 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/cosettes-attempt-drop-438-million-mayne-pharma-deal-denied-by-court-2025-10-15/

REUTERS
15 Oct 2025

https://www.businesswire.com/news/home/20250630266171/en/Cosette-Pharmaceuticals-Appoints-Jeff-Neubig-as-Vice-President-Quality-and-Regulatory-Affairs

BUSINESSWIRE
30 Jun 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/mayne-pharma-slumps-30-cosette-threatens-scrap-432-million-deal-2025-05-21/

REUTERS
21 May 2025
Cosette snaps up Mayne Pharma for $430M
Cosette snaps up Mayne Pharma for $430M

22 Feb 2025

// FIERCE PHARMA

https://www.fiercepharma.com/pharma/cosette-sets-sights-womens-healthcare-stardom-430m-mayne-pharma-buy

FIERCE PHARMA
22 Feb 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty